Report Detail
Global and United States Dihydroartemisinin Market Insights, Forecast to 2026
- RnM4175237 |
- 31 August, 2020 |
- Global |
- 132 Pages |
- QYResearch |
- Chemical & Material
Dihydroartemisinin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Dihydroartemisinin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Dihydroartemisinin market is segmented into
Pharmaceutical Grade
Industrial Grade
Segment by Application, the Dihydroartemisinin market is segmented into
Malaria Treatment
Scientific Research
Others
Regional and Country-level Analysis
The Dihydroartemisinin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dihydroartemisinin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dihydroartemisinin Market Share Analysis
Dihydroartemisinin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dihydroartemisinin business, the date to enter into the Dihydroartemisinin market, Dihydroartemisinin product introduction, recent developments, etc.
The major vendors covered:
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd
1 Study Coverage
- 1.1 Dihydroartemisinin Product Introduction
- 1.2 Market Segments
- 1.3 Key Dihydroartemisinin Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Dihydroartemisinin Market Size Growth Rate by Type
- 1.4.2 Pharmaceutical Grade
- 1.4.3 Industrial Grade
- 1.5 Market by Application
- 1.5.1 Global Dihydroartemisinin Market Size Growth Rate by Application
- 1.5.2 Malaria Treatment
- 1.5.3 Scientific Research
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Dihydroartemisinin Market Size, Estimates and Forecasts
- 2.1.1 Global Dihydroartemisinin Revenue 2015-2026
- 2.1.2 Global Dihydroartemisinin Sales 2015-2026
- 2.2 Global Dihydroartemisinin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Dihydroartemisinin Historical Market Size by Region (2015-2020)
- 2.3.1 Global Dihydroartemisinin Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Dihydroartemisinin Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Dihydroartemisinin Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Dihydroartemisinin Sales Forecast by Region (2021-2026)
- 2.4.2 Global Dihydroartemisinin Revenue Forecast by Region (2021-2026)
3 Global Dihydroartemisinin Competitor Landscape by Players
- 3.1 Global Top Dihydroartemisinin Sales by Manufacturers
- 3.1.1 Global Dihydroartemisinin Sales by Manufacturers (2015-2020)
- 3.1.2 Global Dihydroartemisinin Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Dihydroartemisinin Manufacturers by Revenue
- 3.2.1 Global Dihydroartemisinin Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Dihydroartemisinin Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Dihydroartemisinin Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Dihydroartemisinin Revenue in 2019
- 3.2.5 Global Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Dihydroartemisinin Price by Manufacturers
- 3.4 Global Dihydroartemisinin Manufacturing Base Distribution, Product Types
- 3.4.1 Dihydroartemisinin Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Dihydroartemisinin Product Type
- 3.4.3 Date of International Manufacturers Enter into Dihydroartemisinin Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Dihydroartemisinin Market Size by Type (2015-2020)
- 4.1.1 Global Dihydroartemisinin Sales by Type (2015-2020)
- 4.1.2 Global Dihydroartemisinin Revenue by Type (2015-2020)
- 4.1.3 Dihydroartemisinin Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Dihydroartemisinin Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Dihydroartemisinin Sales Forecast by Type (2021-2026)
- 4.2.2 Global Dihydroartemisinin Revenue Forecast by Type (2021-2026)
- 4.2.3 Dihydroartemisinin Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Dihydroartemisinin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Dihydroartemisinin Market Size by Application (2015-2020)
- 5.1.1 Global Dihydroartemisinin Sales by Application (2015-2020)
- 5.1.2 Global Dihydroartemisinin Revenue by Application (2015-2020)
- 5.1.3 Dihydroartemisinin Price by Application (2015-2020)
- 5.2 Dihydroartemisinin Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Dihydroartemisinin Sales Forecast by Application (2021-2026)
- 5.2.2 Global Dihydroartemisinin Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Dihydroartemisinin Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
- 6.1 United States Dihydroartemisinin Market Size YoY Growth 2015-2026
- 6.1.1 United States Dihydroartemisinin Sales YoY Growth 2015-2026
- 6.1.2 United States Dihydroartemisinin Revenue YoY Growth 2015-2026
- 6.1.3 United States Dihydroartemisinin Market Share in Global Market 2015-2026
- 6.2 United States Dihydroartemisinin Market Size by Players (International and Local Players)
- 6.2.1 United States Top Dihydroartemisinin Players by Sales (2015-2020)
- 6.2.2 United States Top Dihydroartemisinin Players by Revenue (2015-2020)
- 6.3 United States Dihydroartemisinin Historic Market Review by Type (2015-2020)
- 6.3.1 United States Dihydroartemisinin Sales Market Share by Type (2015-2020)
- 6.3.2 United States Dihydroartemisinin Revenue Market Share by Type (2015-2020)
- 6.3.3 United States Dihydroartemisinin Price by Type (2015-2020)
- 6.4 United States Dihydroartemisinin Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 United States Dihydroartemisinin Sales Forecast by Type (2021-2026)
- 6.4.2 United States Dihydroartemisinin Revenue Forecast by Type (2021-2026)
- 6.4.3 United States Dihydroartemisinin Price Forecast by Type (2021-2026)
- 6.5 United States Dihydroartemisinin Historic Market Review by Application (2015-2020)
- 6.5.1 United States Dihydroartemisinin Sales Market Share by Application (2015-2020)
- 6.5.2 United States Dihydroartemisinin Revenue Market Share by Application (2015-2020)
- 6.5.3 United States Dihydroartemisinin Price by Application (2015-2020)
- 6.6 United States Dihydroartemisinin Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 United States Dihydroartemisinin Sales Forecast by Application (2021-2026)
- 6.6.2 United States Dihydroartemisinin Revenue Forecast by Application (2021-2026)
- 6.6.3 United States Dihydroartemisinin Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Dihydroartemisinin Market Size YoY Growth 2015-2026
- 7.2 North America Dihydroartemisinin Market Facts & Figures by Country
- 7.2.1 North America Dihydroartemisinin Sales by Country (2015-2020)
- 7.2.2 North America Dihydroartemisinin Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Dihydroartemisinin Market Size YoY Growth 2015-2026
- 8.2 Europe Dihydroartemisinin Market Facts & Figures by Country
- 8.2.1 Europe Dihydroartemisinin Sales by Country
- 8.2.2 Europe Dihydroartemisinin Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Dihydroartemisinin Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Dihydroartemisinin Market Facts & Figures by Country
- 9.2.1 Asia Pacific Dihydroartemisinin Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Dihydroartemisinin Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Dihydroartemisinin Market Size YoY Growth 2015-2026
- 10.2 Latin America Dihydroartemisinin Market Facts & Figures by Country
- 10.2.1 Latin America Dihydroartemisinin Sales by Country
- 10.2.2 Latin America Dihydroartemisinin Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Dihydroartemisinin Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Dihydroartemisinin Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Dihydroartemisinin Sales by Country
- 11.2.2 Middle East and Africa Dihydroartemisinin Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Sanofi
- 12.1.1 Sanofi Corporation Information
- 12.1.2 Sanofi Description and Business Overview
- 12.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Sanofi Dihydroartemisinin Products Offered
- 12.1.5 Sanofi Recent Development
- 12.2 KPC Pharmaceuticals
- 12.2.1 KPC Pharmaceuticals Corporation Information
- 12.2.2 KPC Pharmaceuticals Description and Business Overview
- 12.2.3 KPC Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 KPC Pharmaceuticals Dihydroartemisinin Products Offered
- 12.2.5 KPC Pharmaceuticals Recent Development
- 12.3 Guangxi Xiancaotang Pharmaceutical
- 12.3.1 Guangxi Xiancaotang Pharmaceutical Corporation Information
- 12.3.2 Guangxi Xiancaotang Pharmaceutical Description and Business Overview
- 12.3.3 Guangxi Xiancaotang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Products Offered
- 12.3.5 Guangxi Xiancaotang Pharmaceutical Recent Development
- 12.4 Guilin Pharmaceutical
- 12.4.1 Guilin Pharmaceutical Corporation Information
- 12.4.2 Guilin Pharmaceutical Description and Business Overview
- 12.4.3 Guilin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Guilin Pharmaceutical Dihydroartemisinin Products Offered
- 12.4.5 Guilin Pharmaceutical Recent Development
- 12.5 Kerui Nanhai Pharmaceutical
- 12.5.1 Kerui Nanhai Pharmaceutical Corporation Information
- 12.5.2 Kerui Nanhai Pharmaceutical Description and Business Overview
- 12.5.3 Kerui Nanhai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Kerui Nanhai Pharmaceutical Dihydroartemisinin Products Offered
- 12.5.5 Kerui Nanhai Pharmaceutical Recent Development
- 12.6 Shanghai Natural Bio-engineering Co
- 12.6.1 Shanghai Natural Bio-engineering Co Corporation Information
- 12.6.2 Shanghai Natural Bio-engineering Co Description and Business Overview
- 12.6.3 Shanghai Natural Bio-engineering Co Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Shanghai Natural Bio-engineering Co Dihydroartemisinin Products Offered
- 12.6.5 Shanghai Natural Bio-engineering Co Recent Development
- 12.7 Novanat Bioresource
- 12.7.1 Novanat Bioresource Corporation Information
- 12.7.2 Novanat Bioresource Description and Business Overview
- 12.7.3 Novanat Bioresource Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Novanat Bioresource Dihydroartemisinin Products Offered
- 12.7.5 Novanat Bioresource Recent Development
- 12.8 Botanical Extracts EPZ Ltd
- 12.8.1 Botanical Extracts EPZ Ltd Corporation Information
- 12.8.2 Botanical Extracts EPZ Ltd Description and Business Overview
- 12.8.3 Botanical Extracts EPZ Ltd Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Botanical Extracts EPZ Ltd Dihydroartemisinin Products Offered
- 12.8.5 Botanical Extracts EPZ Ltd Recent Development
- 12.11 Sanofi
- 12.11.1 Sanofi Corporation Information
- 12.11.2 Sanofi Description and Business Overview
- 12.11.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Sanofi Dihydroartemisinin Products Offered
- 12.11.5 Sanofi Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Dihydroartemisinin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Dihydroartemisinin Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Dihydroartemisinin. Industry analysis & Market Report on Dihydroartemisinin is a syndicated market report, published as Global and United States Dihydroartemisinin Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Dihydroartemisinin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
